【摘要】 2024年，脑血管病临床研究进展显著。全球卒中领域研究者们共同的智慧和努力进一步完善了脑血管病的诊疗和管理策略。在出血性卒中领域，特别是在硬膜下血肿和原发性脑出血的治疗方面，研究取得了令人振奋的突破性进展。同时，缺血性卒中作为近年来的研究热点，在静脉溶栓、动脉取栓和二级预防等多个方面，不断涌现出更多高质量的研究成果，为临床诊疗提供了更多、更坚实的证据。本文将对2024年脑血管病领域的关键临床研究结果进行总结和解读，旨在帮助读者更好地把握当前的研究热点，深入理解其意义。更多还原

【Abstract】 In 2024, significant advancements were made in clinical research on cerebrovascular diseases. Stroke researchers worldwide have actively contributed their expertise, and further refined the diagnosis, treatment, and management strategies for cerebrovascular diseases. Exciting breakthroughs have been made in the field of hemorrhagic stroke, including the treatment of subdural hematoma and primary intracerebral hemorrhage. At the same time, as a research hotspot in recent years, ischemic stroke has seen a continuous emergence of high-quality research results in various aspects such as intravenous thrombolysis, arterial thrombectomy, and secondary prevention, providing more robust evidence for clinical diagnosis and treatment. This article aims to summarize and interpret the key clinical research findings in the field of cerebrovascular diseases in 2024, providing readers with a better understanding of the current research hotspots and deeply understand their significance.更多还原